Fmr LLC increased its position in shares of National Health Investors Inc (NYSE:NHI) by 0.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 759,702 shares of the real estate investment trust’s stock after purchasing an additional 873 shares during the quarter. Fmr LLC owned 1.80% of National Health Investors worth $57,426,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in NHI. BlackRock Inc. lifted its holdings in shares of National Health Investors by 4.7% during the second quarter. BlackRock Inc. now owns 4,026,546 shares of the real estate investment trust’s stock worth $296,676,000 after purchasing an additional 182,378 shares during the period. Bank of America Corp DE raised its position in National Health Investors by 34.4% during the second quarter. Bank of America Corp DE now owns 478,340 shares of the real estate investment trust’s stock valued at $35,245,000 after acquiring an additional 122,484 shares in the last quarter. LSV Asset Management raised its position in National Health Investors by 37.9% during the second quarter. LSV Asset Management now owns 410,248 shares of the real estate investment trust’s stock valued at $30,227,000 after acquiring an additional 112,648 shares in the last quarter. NN Investment Partners Holdings N.V. purchased a new position in National Health Investors during the third quarter valued at approximately $8,091,000. Finally, American Century Companies Inc. purchased a new position in National Health Investors during the third quarter valued at approximately $5,651,000. 69.28% of the stock is owned by hedge funds and other institutional investors.

NHI has been the subject of several recent research reports. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research report on Tuesday, October 9th. Cantor Fitzgerald reiterated a “hold” rating and set a $80.00 price target on shares of National Health Investors in a research report on Thursday, November 8th. ValuEngine upgraded National Health Investors from a “hold” rating to a “buy” rating in a research report on Tuesday, December 11th. Finally, Wells Fargo & Co reiterated a “hold” rating on shares of National Health Investors in a research report on Tuesday, August 28th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $75.22.

In other news, Director Robert A. Mccabe, Jr. sold 1,250 shares of the business’s stock in a transaction that occurred on Monday, November 26th. The stock was sold at an average price of $75.41, for a total value of $94,262.50. Following the completion of the sale, the director now directly owns 13,120 shares in the company, valued at $989,379.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kristin Sallee Gaines sold 10,708 shares of the business’s stock in a transaction that occurred on Thursday, December 13th. The shares were sold at an average price of $80.36, for a total value of $860,494.88. Following the completion of the sale, the insider now owns 43,644 shares of the company’s stock, valued at $3,507,231.84. The disclosure for this sale can be found here. 5.63% of the stock is owned by insiders.

Shares of NHI stock opened at $76.90 on Tuesday. The company has a market cap of $3.35 billion, a P/E ratio of 14.43, a P/E/G ratio of 3.73 and a beta of 0.34. National Health Investors Inc has a twelve month low of $62.71 and a twelve month high of $81.60. The company has a debt-to-equity ratio of 0.89, a current ratio of 14.53 and a quick ratio of 14.53.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, November 6th. The real estate investment trust reported $0.97 EPS for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.42). The business had revenue of $74.92 million during the quarter, compared to analysts’ expectations of $73.72 million. National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.37 earnings per share. As a group, equities analysts predict that National Health Investors Inc will post 5.51 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Fmr LLC Grows Position in National Health Investors Inc (NHI)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2018/12/18/fmr-llc-grows-position-in-national-health-investors-inc-nhi.html.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Federal Reserve

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.